Clopidogrel (Pharmacogenetics)
Clopidogrel sold under the brand name Plavix is a widely used antiplatelet agent to treat and prevent a variety of atherothrombotic diseases.
Research has implicated genetic variations in the CYP2C19 isozyme as at least partly responsible for the variable antiplatelet response seen with clopidogrel.